Literature DB >> 28055945

Comment on "Individual and Neighborhood Socioeconomic Status and the Association between Air Pollution and Cardiovascular Disease".

Tara Ahmed1, Heval Mohamed Kelli, Pratik Sandesara.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28055945      PMCID: PMC5226706          DOI: 10.1289/EHP852

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


× No keyword cloud information.
We read with great interest Chi et al.’s article examining the role of socioeconomic status (SES) in the air pollution–cardiovascular disease (CVD) relationship. We appreciate their consideration of multiple levels of SES in this relationship. The authors have paved the path to consider similar studies on other populations. However, we note that, given the composition of the study population, the findings of this report can be generalized only to a subset of the population who are female, white, postmenopausal, over 50 years old, and free of CVD at baseline. In order for the findings to apply to the general population, potential differences related to factors such as sex and race would need to be considered. As CVD research has grown to include more female participants, significant sex differences have recently been found. Atypical presentation of CVD is more prevalent in women than in men (Canto et al. 2012; Ski et al. 2014). Moreover, the sex disparity in evidence-based treatment can lead to delayed intervention and adverse cardiovascular outcomes (Ski et al. 2014). In addition, the risk for cardiovascular complications in diabetics is higher in women than in men (Huxley et al. 2006; Maas and Appelman 2010). Since there are substantial sex differences in CVD, there may also be sex differences in the role of SES in the association between air pollution and CVD. While the article provides relatively recent findings, its applicability to current populations is limited due to the data collection timeline. Participants were initially enrolled between 1993 and 1998. This enrollment period occurred before a crucial turning point in health care, specifically the 1999 release of the first woman-specific clinical recommendations by the American Heart Association (Lewis et al. 2009; Mosca et al. 2011; Ski et al. 2014). Since the release of the recommendations, there have been major improvements and changes in risk factor awareness, prevention, and treatment of CVD in women (Lewis et al. 2009; Mosca et al. 2011; Ski et al. 2014). Furthermore, in 2004 the American Heart Association published the first evidence-based guidelines for female CVD prevention, and the rate of death from CVD among women decreased by nearly half between 1997 and 2009 (Mosca et al. 2011). Therefore, if the same study were conducted today, we speculate that the findings might be different based on these more recent improvements in women’s CVD awareness, prevention, and treatment. In addition to sex differences, notable differences in CVD have been associated with racial and ethnic differences. CVD, related risk factors, and mortality have occurred at a higher prevalence in black individuals than in white individuals (Feinstein et al. 2012; Ski et al. 2014). For example, the prevalence of CVD in black women is 47%, compared with 34% in white women (Mosca et al. 2011; Roger et al. 2011). In 2007 the rate of hypertension as a cause of death in black women was nearly double the rate in white women (Mosca et al. 2011; Roger et al. 2011). These differences emphasize the need to consider potential racial disparities, as well as sex disparities, when examining the role of SES in the air pollution–CVD relationship. Finally, Chi et al. excluded 18,576 participants for having CVD at baseline. While their findings have implications for preventing CVD outcomes in individuals who initially lack CVD, it would also be informative to conduct a similar study in those who do have CVD at baseline. Such a study could yield insight into individuals’ susceptibility to progression of CVD, related hospitalizations or mortality, comorbidities, and overall health.
  8 in total

1.  Heart disease and stroke statistics--2011 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Robert J Adams; Jarett D Berry; Todd M Brown; Mercedes R Carnethon; Shifan Dai; Giovanni de Simone; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Kurt J Greenlund; Susan M Hailpern; John A Heit; P Michael Ho; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Mary M McDermott; James B Meigs; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Wayne D Rosamond; Paul D Sorlie; Randall S Stafford; Tanya N Turan; Melanie B Turner; Nathan D Wong; Judith Wylie-Rosett
Journal:  Circulation       Date:  2010-12-15       Impact factor: 29.690

2.  Sex/gender differences in cardiovascular disease prevention: what a difference a decade makes.

Authors:  Lori Mosca; Elizabeth Barrett-Connor; Nanette Kass Wenger
Journal:  Circulation       Date:  2011-11-08       Impact factor: 29.690

Review 3.  Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies.

Authors:  Rachel Huxley; Federica Barzi; Mark Woodward
Journal:  BMJ       Date:  2005-12-21

4.  Gender differences in coronary heart disease.

Authors:  A H E M Maas; Y E A Appelman
Journal:  Neth Heart J       Date:  2010-12       Impact factor: 2.380

5.  Racial differences in risks for first cardiovascular events and noncardiovascular death: the Atherosclerosis Risk in Communities study, the Cardiovascular Health Study, and the Multi-Ethnic Study of Atherosclerosis.

Authors:  Matthew Feinstein; Hongyan Ning; Joseph Kang; Alain Bertoni; Mercedes Carnethon; Donald M Lloyd-Jones
Journal:  Circulation       Date:  2012-06-12       Impact factor: 29.690

6.  Association of age and sex with myocardial infarction symptom presentation and in-hospital mortality.

Authors:  John G Canto; William J Rogers; Robert J Goldberg; Eric D Peterson; Nanette K Wenger; Viola Vaccarino; Catarina I Kiefe; Paul D Frederick; George Sopko; Zhi-Jie Zheng
Journal:  JAMA       Date:  2012-02-22       Impact factor: 56.272

7.  Gender, socioeconomic and ethnic/racial disparities in cardiovascular disease: a time for change.

Authors:  Chantal F Ski; Kathryn M King-Shier; David R Thompson
Journal:  Int J Cardiol       Date:  2013-11-01       Impact factor: 4.164

8.  Trends in the use of evidence-based treatments for coronary artery disease among women and the elderly: findings from the get with the guidelines quality-improvement program.

Authors:  William R Lewis; A Gray Ellrodt; Eric Peterson; Adrian F Hernandez; Kenneth A LaBresh; Christopher P Cannon; Wenqin Pan; Gregg C Fonarow
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2009-10-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.